Anagenics Ltd has released a press release.
Cellmids Alopecia Patent Allowed in Australia and Japan
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Anagenics
- Independent Test Results For The Wondfo SARS-CoV-2 Test
- Cellmids Shipment of SARS-CoV-2 Tests Received
- Reinstatement to Official Quotation
- Response to ASX Query Letter
- Market Update on COVID-19
Later from Anagenics
- Appointment of Dr Dominic Burg as Chief Operating Officer
- CDY signs Introducer Agreement to broaden product offering
- Cellmid Reports on Results of The Doherty Institute Testing
- Cellmid Reports on Strong QVC Sales Event
- Extension Of Wondfo Rapid Test Distribution Agreement
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics